Intas Pharmaceuticals Limited Pioglitazone Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Pioglitazone Export Records India — #3 Exporter, 473 Shipments, $3.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Pioglitazone

India Pharmaceutical Trade Intelligence

$37.3M115 Suppliers70 CountriesHS 30049099

ExportsIndia → UNITED STATES60.5%India → PHILIPPINES7.8%

ImportsUNITED STATES → India$30.6K BRAZIL → India$4.5K

#1 Buyer: RISING PHARMA

Intas Pharmaceuticals Limited — Pioglitazone Exporter #3 | $3.8M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Pioglitazone Exporter Profile

Indian Pharmaceutical Exporter · #3 for Pioglitazone · $3.8M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #3 Indian exporter of Pioglitazone with $3.8M in export value and 473 verified shipments. Intas Pharmaceuticals Limited holds a 9.1% market share in Pioglitazone exports across 11 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Pioglitazone Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Pioglitazone export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Pioglitazone?

Country	Value	Shipments	Share
ITALY	$903.5K	56	28.1%
CROATIA	$790.7K	40	24.6%
POLAND	$640.1K	86	19.9%
UNITED KINGDOM	$453.1K	97

Who Are the Top Buyers of Pioglitazone from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
TO THE ORDER	ITALY	$482.9K	30
ACCORD UK	UNITED KINGDOM	$452.6K	61
NOVATIN LIMITED	CROATIA	$288.0K	9
S.C.F. SRL	ITALY	$265.0K	11
S C F SRL	ITALY	$240.4K	9
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$207.7K	7
BIOTON S.A.	POLAND	$205.5K	24
BIOTON S A	POLAND	$130.2K	6
NOVATIN LTD CONSIGNEMENT STOCK	CROATIA	$128.0K	10
NOVATIN LTD	CROATIA	$115.2K	3

Intas Pharmaceuticals Limited supplies Pioglitazone to 36 buyers globally. The largest buyer is TO THE ORDER (ITALY), followed by ACCORD UK (UNITED KINGDOM) and NOVATIN LIMITED (CROATIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Pioglitazone Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PH.DRU.& MED.: NOVAPIO PIOGLITAZONE 30MGTABLETS EACH TABLET CONTAINS: PIOGLITAZONE HCL 30MG [2X15T PER PACK] BATCH NO	$288.0K	9
PHARMA DRUGS & MEDI PIOGLITAZONE TABLETS	$200.8K	6
PHARMACEUTICAL DRUGS & MEDICINE.PIOGLITAZONE 30MG 2X14T (DOC ITALY EACH UNCOATEDTABLET CONTS.PIOGLITAZONE HYDROCHLORIDE	$136.6K	5
PH. DRU & MEDI PIOGLITAZONE 30MG 2X14T(EACH UNCOATED TAB. CONTAINS PIOGLITAZONE HYDROCHLORIDE EQ.TOPIOGLITAZONE 30MGTBS	$101.0K	12
PHARM.DRUGS&MEDI.PIOGLITAZONE 15MG 2X14T	$100.2K	3
PH.DRU.& MED.: PIOGLITAZONE 15MG TABLETS	$97.2K	18
PHARMA DRUGS & MEDI PIOGLITAZONE 45MG 2X14T(ACCORD-UK AS PER INVOICE	$90.9K	5
PH.DRU.& MED.PIOGLITAZONE 15MG 2X14T(DOC ITALY EACH UNC. TAB CONTA. PIOGLITAZONE HYDROCHLORIDE EQ. TO PIOGLITAZONE 15 MG	$89.9K	3
PH.DRU.& MED.: PIOGLITAZONE 30MG TABLETS	$89.4K	18
PHARMA DRUGS & MEDI PIOGLITAZONE 45MG 2X	$86.1K	13

Intas Pharmaceuticals Limited exports 178 distinct Pioglitazone formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PH.DRU.& MED.: NOVAPIO PIOGLITAZONE 30MGTABLETS EACH TABLET with 9 shipments worth $288.0K.

How Does Intas Pharmaceuticals Limited Compare to Nearest Pioglitazone Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	AUROBINDO PHARMA LTD	$15.2M	547	4	$27.7K
2	AUROBINDO PHARMA LIMITED	$4.0M	161	5	$24.9K
3	INTAS PHARMACEUTICALS LIMITED ★	$3.4M	473	11	$7.2K
4	MACLEODS PHARMACEUTICALS LTD	$3.3M	311	2	$10.7K
5	AJANTA PHARMA LIMITED	$1.8M	36	2	$48.9K

Intas Pharmaceuticals Limited ranks #3 among 115 Indian Pioglitazone exporters. Average shipment value of $7.2K compared to the market average of $305.7K. The closest competitors by value are AUROBINDO PHARMA LTD and AUROBINDO PHARMA LIMITED.

Which Indian Ports Ship Pioglitazone Exports?

Port	Shipments	% Share
DELHI AIR	249	9.3%
HYDERABAD ICD	229	8.6%
DELHI AIR CARGO ACC (INDEL4)	206	7.7%
SAHAR AIR	205	7.7%
HYDERABAD ICD (INSNF6)	203	7.6%
SAHAR AIR CARGO ACC (INBOM4)	143	5.3%
MUNDRA SEA	127	4.7%
CMA CGM LOGISTICS PARK ICD	126	4.7%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Pioglitazone Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Pioglitazone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 502 individual customs records matching Intas Pharmaceuticals Limited exporting Pioglitazone, covering 178 formulations to 11 countries via 36 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 70+ countries, 293+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Pioglitazone

Pioglitazone

Intas Pharmaceuticals Limited — Pioglitazone Exporter Profile

Intas Pharmaceuticals Limited — Pioglitazone Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Pioglitazone?

Who Are the Top Buyers of Pioglitazone from Intas Pharmaceuticals Limited?

What Is India's Total Pioglitazone Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Pioglitazone Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Pioglitazone Exporters?

What Pioglitazone Formulations Does Intas Pharmaceuticals Limited Export?

How Does Intas Pharmaceuticals Limited Compare to Nearest Pioglitazone Exporters?

Which Indian Ports Ship Pioglitazone Exports?

What Other Diabetes & Endocrine Products Does Intas Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Pioglitazone Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Pioglitazone Export Data from Intas Pharmaceuticals Limited

Pioglitazone Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source